These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 1841815

  • 1. Postprandial hyperglycemia and pancreatic function in cystic fibrosis patients.
    Hinds A, Sheehan AG, Machida H, Parsons HG.
    Diabetes Res; 1991 Oct; 18(2):69-78. PubMed ID: 1841815
    [Abstract] [Full Text] [Related]

  • 2. Tolbutamide causes a modest increase in insulin secretion in cystic fibrosis patients with impaired glucose tolerance.
    Hinds A, Sheehan AG, Parsons HG.
    Metabolism; 1995 Jan; 44(1):13-8. PubMed ID: 7854158
    [Abstract] [Full Text] [Related]

  • 3. Hypoglycemia and Islet Dysfunction Following Oral Glucose Tolerance Testing in Pancreatic-Insufficient Cystic Fibrosis.
    Kilberg MJ, Harris C, Sheikh S, Stefanovski D, Cuchel M, Kubrak C, Hadjiliadis D, Rubenstein RC, Rickels MR, Kelly A.
    J Clin Endocrinol Metab; 2020 Oct 01; 105(10):3179-89. PubMed ID: 32668452
    [Abstract] [Full Text] [Related]

  • 4. Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance.
    Lanng S, Thorsteinsson B, Røder ME, Orskov C, Holst JJ, Nerup J, Koch C.
    Acta Endocrinol (Copenh); 1993 Mar 01; 128(3):207-14. PubMed ID: 8480468
    [Abstract] [Full Text] [Related]

  • 5. Normal secretion and action of the gut incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in young men with low birth weight.
    Schou JH, Pilgaard K, Vilsbøll T, Jensen CB, Deacon CF, Holst JJ, Vølund A, Madsbad S, Vaag AA.
    J Clin Endocrinol Metab; 2005 Aug 01; 90(8):4912-9. PubMed ID: 15899957
    [Abstract] [Full Text] [Related]

  • 6. Hypoglycemia in cystic fibrosis during an extended oral glucose tolerance test.
    Armaghanian N, Hetherington J, Parameswaran V, Chua EL, Markovic TP, Brand-Miller J, Steinbeck K.
    Pediatr Pulmonol; 2020 Dec 01; 55(12):3391-3399. PubMed ID: 32955169
    [Abstract] [Full Text] [Related]

  • 7. Gastric emptying, incretin hormone secretion, and postprandial glycemia in cystic fibrosis--effects of pancreatic enzyme supplementation.
    Kuo P, Stevens JE, Russo A, Maddox A, Wishart JM, Jones KL, Greville H, Hetzel D, Chapman I, Horowitz M, Rayner CK.
    J Clin Endocrinol Metab; 2011 May 01; 96(5):E851-5. PubMed ID: 21389144
    [Abstract] [Full Text] [Related]

  • 8. Interaction of fat-stimulated gastric inhibitory polypeptide on pancreatic alpha and beta cell function.
    Verdonk CA, Rizza RA, Nelson RL, Go VL, Gerich JE, Service FJ.
    J Clin Invest; 1980 May 01; 65(5):1119-25. PubMed ID: 6988457
    [Abstract] [Full Text] [Related]

  • 9. Patients With Long-QT Syndrome Caused by Impaired hERG-Encoded Kv11.1 Potassium Channel Have Exaggerated Endocrine Pancreatic and Incretin Function Associated With Reactive Hypoglycemia.
    Hyltén-Cavallius L, Iepsen EW, Wewer Albrechtsen NJ, Svendstrup M, Lubberding AF, Hartmann B, Jespersen T, Linneberg A, Christiansen M, Vestergaard H, Pedersen O, Holst JJ, Kanters JK, Hansen T, Torekov SS.
    Circulation; 2017 May 02; 135(18):1705-1719. PubMed ID: 28235848
    [Abstract] [Full Text] [Related]

  • 10. Reduced β-Cell Secretory Capacity in Pancreatic-Insufficient, but Not Pancreatic-Sufficient, Cystic Fibrosis Despite Normal Glucose Tolerance.
    Sheikh S, Gudipaty L, De Leon DD, Hadjiliadis D, Kubrak C, Rosenfeld NK, Nyirjesy SC, Peleckis AJ, Malik S, Stefanovski D, Cuchel M, Rubenstein RC, Kelly A, Rickels MR.
    Diabetes; 2017 Jan 02; 66(1):134-144. PubMed ID: 27495225
    [Abstract] [Full Text] [Related]

  • 11. Reduced postprandial GLP-1 responses in women with gestational diabetes mellitus.
    Bonde L, Vilsbøll T, Nielsen T, Bagger JI, Svare JA, Holst JJ, Larsen S, Knop FK.
    Diabetes Obes Metab; 2013 Aug 02; 15(8):713-20. PubMed ID: 23406269
    [Abstract] [Full Text] [Related]

  • 12. Cystic fibrosis-related diabetes: the role of peripheral insulin resistance and beta-cell dysfunction.
    Yung B, Noormohamed FH, Kemp M, Hooper J, Lant AF, Hodson ME.
    Diabet Med; 2002 Mar 02; 19(3):221-6. PubMed ID: 11963922
    [Abstract] [Full Text] [Related]

  • 13. The Shape of the Glucose Response Curve During an Oral Glucose Tolerance Test Heralds Biomarkers of Type 2 Diabetes Risk in Obese Youth.
    Kim JY, Michaliszyn SF, Nasr A, Lee S, Tfayli H, Hannon T, Hughan KS, Bacha F, Arslanian S.
    Diabetes Care; 2016 Aug 02; 39(8):1431-9. PubMed ID: 27293201
    [Abstract] [Full Text] [Related]

  • 14. Carbohydrate tolerance in cystic fibrosis is closely linked to pancreatic exocrine function.
    Geffner ME, Lippe BM, Kaplan SA, Itami RM, Gillard BK, Levin SR, Taylor IL.
    Pediatr Res; 1984 Nov 02; 18(11):1107-11. PubMed ID: 6083538
    [Abstract] [Full Text] [Related]

  • 15. Impaired counterregulatory responses to hypoglycaemia following oral glucose in adults with cystic fibrosis.
    Aitken ML, Szkudlinska MA, Boyko EJ, Ng D, Utzschneider KM, Kahn SE.
    Diabetologia; 2020 May 02; 63(5):1055-1065. PubMed ID: 31993716
    [Abstract] [Full Text] [Related]

  • 16. Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients.
    Toft-Nielsen MB, Damholt MB, Madsbad S, Hilsted LM, Hughes TE, Michelsen BK, Holst JJ.
    J Clin Endocrinol Metab; 2001 Aug 02; 86(8):3717-23. PubMed ID: 11502801
    [Abstract] [Full Text] [Related]

  • 17. Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.
    Nauck MA, Heimesaat MM, Orskov C, Holst JJ, Ebert R, Creutzfeldt W.
    J Clin Invest; 1993 Jan 02; 91(1):301-7. PubMed ID: 8423228
    [Abstract] [Full Text] [Related]

  • 18. Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.
    Vilsbøll T, Krarup T, Deacon CF, Madsbad S, Holst JJ.
    Diabetes; 2001 Mar 02; 50(3):609-13. PubMed ID: 11246881
    [Abstract] [Full Text] [Related]

  • 19. Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance.
    Rask E, Olsson T, Söderberg S, Holst Jj Jj, Tura A, Pacini G, Ahrén B.
    Metabolism; 2004 May 02; 53(5):624-31. PubMed ID: 15131768
    [Abstract] [Full Text] [Related]

  • 20. Enhanced glucose-dependent insulinotropic polypeptide secretion and insulinotropic action in glucagon-like peptide 1 receptor -/- mice.
    Pederson RA, Satkunarajah M, McIntosh CH, Scrocchi LA, Flamez D, Schuit F, Drucker DJ, Wheeler MB.
    Diabetes; 1998 Jul 02; 47(7):1046-52. PubMed ID: 9648827
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.